Year-over-year earnings per share growth for the last twelve months: Praxis Precision Medicines (PRAX)

Symbol and logo of brand Praxis Corp (PRAX)

Praxis Precision Medicines (PRAX) possesses monopoly pricing power due to its unique impact on ion channels. The quarterly EPS growth rate, as reflected in GURU.Markets quotes, demonstrates a trend where 4.10 becomes the new value for this metric. High R&D expenses limit scaling until drugs are brought to market, and current revenue is based on grants and partnerships without any approved products.

PRAX: Praxis Precision Medicines, Inc. Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/16/2026

Praxis Precision Medicines (PRAX) - metric breakdowns and financial figures

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Praxis Corp - PRAX
Manufactured product of Praxis Corp

Quarterly EPS growth reflects the change in net income per share compared to the same period last year. This metric measures the efficiency of business capitalization, accounting for operating expenses and net income. By analyzing the quarterly EPS chart, an investor assesses the sustainability of profitability rates. For Praxis Precision Medicines (PRAX), this metric demonstrates the financial results derived from the development of targeted epilepsy therapy. Growth in this indicator confirms the commercial success of a precision approach to treating genetic disorders.

Main competitors

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Quarterly EPS earnings growth Trevi Corp|Year-over-year net earnings per share growth for the last 12 months AVXL (Anavex Life Sciences)|Year-over-year net earnings per share growth for the last 12 months CeriBell CBLL|Year-over-year earnings per share growth for the last twelve months Prothena Biosciences PRTA|Quarterly EPS earnings growth Alector, Inc. ALEC|ANNX - Year-over-year earnings per share growth for the last twelve months|OMER - Quarterly EPS earnings growth|Neurogene (NGNE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months AC Immune SA (ACIU)|Year-over-year net earnings per share growth for the last 12 months VYGR|Quarterly EPS earnings growth Neumora Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months scilexholding.com (SCLX)|Year-over-year net earnings per share change for the last twelve months Tevogen Bio Inc.|Year-over-year earnings per share growth for the last twelve months Alpha Cognition Inc. ACOG|Quarterly EPS earnings growth Cognition Therapeutics CGTX|IKT: Year-over-year net earnings per share growth for the last 12 months|SAVA (Cassava Sciences) - Year-over-year earnings per share growth for the last 12 months|Assertio Holdings, Inc. (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last twelve months Vistagen|Year-over-year net earnings per share growth for the last 12 months Ovid Therapeutics (OVID)|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Earnings per share growth in annualized terms for the last twelve months|Alterity Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CLNN: Year-over-year earnings per share growth for the last 12 months|pepgen.com - Quarterly EPS earnings growth|JUNS (Jupiter Neurosciences) - Year-over-year earnings per share growth for the last 12 months|Relmada (RLMD) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Quarterly EPS earnings growth|Firefly Neuroscience Inc (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical Technologies, Inc. HSDT|PASG: Quarterly EPS earnings growth|Neuphoria (NEUP) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ADXN (Addex Therapeutics)|Quarterly EPS earnings growth Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|PTIX (Protagenic Therapeutics) - Year-over-year net earnings per share trend for the last twelve months|Pasithea Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)